Christopher C. Caillouet

Array ( [id] => 8538536 [patent_doc_number] => 08314257 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Treatment of CRTH2-mediated diseases and conditions' [patent_app_type] => utility [patent_app_number] => 12/232447 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9937 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12232447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146916 [patent_doc_number] => 08163931 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Treatment of CRTH2-mediated diseases and conditions' [patent_app_type] => utility [patent_app_number] => 12/232444 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9938 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163931.pdf [firstpage_image] =>[orig_patent_app_number] => 12232444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310857 [patent_doc_number] => 20090018138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Treatment of CRTH2-mediated diseases and conditions' [patent_app_type] => utility [patent_app_number] => 12/232446 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9891 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018138.pdf [firstpage_image] =>[orig_patent_app_number] => 12232446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5311057 [patent_doc_number] => 20090018338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Treatment of CRTH2-Mediated diseases and conditions' [patent_app_type] => utility [patent_app_number] => 12/232445 [patent_app_country] => US [patent_app_date] => 2008-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9894 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018338.pdf [firstpage_image] =>[orig_patent_app_number] => 12232445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146759 [patent_doc_number] => 08163772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3-carboxamide' [patent_app_type] => utility [patent_app_number] => 12/283702 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 19923 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163772.pdf [firstpage_image] =>[orig_patent_app_number] => 12283702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5576065 [patent_doc_number] => 20090143427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => '4-Oxoquinoline derivatives' [patent_app_type] => utility [patent_app_number] => 12/283620 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9264 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143427.pdf [firstpage_image] =>[orig_patent_app_number] => 12283620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272296 [patent_doc_number] => 20090076072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DEUTERIUM-ENRICHED TAFENOQUINE' [patent_app_type] => utility [patent_app_number] => 12/206330 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3512 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076072.pdf [firstpage_image] =>[orig_patent_app_number] => 12206330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8802320 [patent_doc_number] => 08440595 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Fungicides' [patent_app_type] => utility [patent_app_number] => 12/676702 [patent_app_country] => US [patent_app_date] => 2008-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13444 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12676702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276150 [patent_doc_number] => 20100256183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'FUNGICIDAL 2-ALKYLTHIO-2-QUINOLINYLOXY-ACETAMIDE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/676382 [patent_app_country] => US [patent_app_date] => 2008-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11578 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256183.pdf [firstpage_image] =>[orig_patent_app_number] => 12676382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4508219 [patent_doc_number] => 07915291 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Hepatitis C virus inhibitors' [patent_app_type] => utility [patent_app_number] => 12/202603 [patent_app_country] => US [patent_app_date] => 2008-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 171911 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915291.pdf [firstpage_image] =>[orig_patent_app_number] => 12202603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5522216 [patent_doc_number] => 20090030197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Quinoline Intermediates of Receptor Tyrosine Kinase Inhibitors and the Synthesis Thereof' [patent_app_type] => utility [patent_app_number] => 12/200120 [patent_app_country] => US [patent_app_date] => 2008-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7536 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20090030197.pdf [firstpage_image] =>[orig_patent_app_number] => 12200120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485791 [patent_doc_number] => 20090275556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Aryl sulfonamides useful as inhibitors of chemokine receptor activity' [patent_app_type] => utility [patent_app_number] => 12/229818 [patent_app_country] => US [patent_app_date] => 2008-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86868 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275556.pdf [firstpage_image] =>[orig_patent_app_number] => 12229818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6547578 [patent_doc_number] => 20100222346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => '4-BENZYLAMINOQUINOLINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY' [patent_app_type] => utility [patent_app_number] => 12/666629 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24848 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222346.pdf [firstpage_image] =>[orig_patent_app_number] => 12666629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071326 [patent_doc_number] => 20110046177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'THERAPEUTIC QUINOLINE AND NAPHTHALENE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/674180 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3728 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046177.pdf [firstpage_image] =>[orig_patent_app_number] => 12674180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558778 [patent_doc_number] => 20090270355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Compounds' [patent_app_type] => utility [patent_app_number] => 12/190868 [patent_app_country] => US [patent_app_date] => 2008-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 39518 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270355.pdf [firstpage_image] =>[orig_patent_app_number] => 12190868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759995 [patent_doc_number] => 20080312221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'QUINOLINE DERIVATIVE AND QUINAZOLINE DERIVATIVE INHIBITING SELF-PHOSPHORYLATION OF HEPATOCYTUS PROLIFERATOR RECEPTOR, AND MEDICINAL COMPOSITION CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/175361 [patent_app_country] => US [patent_app_date] => 2008-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43940 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312221.pdf [firstpage_image] =>[orig_patent_app_number] => 12175361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4711710 [patent_doc_number] => 20080300236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/174017 [patent_app_country] => US [patent_app_date] => 2008-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 59458 [patent_no_of_claims] => 138 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20080300236.pdf [firstpage_image] =>[orig_patent_app_number] => 12174017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6468911 [patent_doc_number] => 20100190987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'PROCESS AND INTERMEDIATE FOR THE PRODUCTION OF A TERTIARY ALCOHOL AS AN INTERMEDIATE IN THE SYNTHESIS OF MONTELUKAST' [patent_app_type] => utility [patent_app_number] => 12/668320 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2622 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190987.pdf [firstpage_image] =>[orig_patent_app_number] => 12668320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519051 [patent_doc_number] => 20100217004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'PROCESS FOR THE PRODUCTION OF TERTIARY ALCOHOLS' [patent_app_type] => utility [patent_app_number] => 12/668100 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3728 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20100217004.pdf [firstpage_image] =>[orig_patent_app_number] => 12668100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6403066 [patent_doc_number] => 20100179325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-15 [patent_title] => 'COMPOUND HAVING 11BETA-HSD1 INHIBITORY ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/666802 [patent_app_country] => US [patent_app_date] => 2008-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31058 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20100179325.pdf [firstpage_image] =>[orig_patent_app_number] => 12666802 [rel_patent_id] =>[rel_patent_doc_number] =>)